subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now
Aspen Pharmacare. Picture: SUPPLIED
Aspen Pharmacare. Picture: SUPPLIED

Aspen says it has delivered a solid year-end performance. The multinational pharmaceutical company has posted revenue growth of 10%, supported by its manufacturing division, but its bottom line came under pressure. Business Day TV unpacked the performance with Aspen Group CEO Stephen Saad.

subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.